$ASMB
Assembly Biosciences Inc

2015 Q2 Form 10-Q Financial Statement

#000114420415028776 Filed on May 08, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2015 Q1 2014 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.490M $3.370M $1.140M
YoY Change 76.6% 195.61% -1.72%
% of Gross Profit
Research & Development $4.668M $3.834M $2.974M
YoY Change 326.03% 28.95% 13.97%
% of Gross Profit
Depreciation & Amortization $16.00K $13.90K $1.266K
YoY Change 1459.45% 998.26% -0.08%
% of Gross Profit
Operating Expenses $4.668M $3.834M $2.974M
YoY Change 326.03% 28.95% 13.97%
Operating Profit -$7.154M -$7.203M -$4.110M
YoY Change 185.45% 75.25% 9.05%
Interest Expense $210.0K $60.00K $40.00K
YoY Change 425.0% 50.0% -20.0%
% of Operating Profit
Other Income/Expense, Net $211.2K $58.27K $40.23K
YoY Change 44.82%
Pretax Income -$6.940M -$7.140M -$4.070M
YoY Change 180.97% 75.43% 9.41%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.943M -$7.145M -$4.070M
YoY Change 181.16% 75.56% 9.32%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$405.4K -$638.6K -$920.8K
COMMON SHARES
Basic Shares Outstanding 17.18M shares 10.70M shares 23.40M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $70.70M $96.10M $23.60M
YoY Change 231.92% 307.2% -36.04%
Cash & Equivalents $53.52M $96.05M $23.64M
Short-Term Investments $17.20M
Other Short-Term Assets $605.2K $283.8K $259.2K
YoY Change 252.75% 9.51% 29.6%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $71.33M $96.34M $23.90M
YoY Change 228.0% 303.16% -35.59%
LONG-TERM ASSETS
Property, Plant & Equipment $174.0K $173.2K $8.425K
YoY Change 2252.14% 1956.36%
Goodwill $12.74M
YoY Change
Intangibles $29.00M
YoY Change
Long-Term Investments $31.60M $100.0K
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $73.37M $41.96M $8.425K
YoY Change 991579.58% 497966.26%
TOTAL ASSETS
Total Short-Term Assets $71.33M $96.34M $23.90M
Total Long-Term Assets $73.37M $41.96M $8.425K
Total Assets $144.7M $138.3M $23.90M
YoY Change 565.16% 478.56% -35.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.300M $1.300M $1.435M
YoY Change -8.54% -9.42% -4.32%
Accrued Expenses $935.7K $877.5K $27.25K
YoY Change 1831.8% 3120.45% -93.19%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.240M $2.128M $1.500M
YoY Change 49.33% 41.89% -25.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $11.60M $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.240M $2.128M $1.500M
Total Long-Term Liabilities $11.60M $0.00 $0.00
Total Liabilities $13.84M $13.70M $1.462M
YoY Change 841.63% 836.78% -26.88%
SHAREHOLDERS EQUITY
Retained Earnings -$149.6M -$142.7M
YoY Change
Common Stock $17.19K $23.40K
YoY Change 267.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $130.9M $124.6M $22.44M
YoY Change
Total Liabilities & Shareholders Equity $144.7M $138.3M $23.90M
YoY Change 565.13% 478.75% -35.57%

Cashflow Statement

Concept 2015 Q2 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$6.943M -$7.145M -$4.070M
YoY Change 181.16% 75.56% 9.32%
Depreciation, Depletion And Amortization $16.00K $13.90K $1.266K
YoY Change 1459.45% 998.26% -0.08%
Cash From Operating Activities -$4.390M -$3.673M -$5.185M
YoY Change 89.22% -29.16% 18.65%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K $30.71K $2.589K
YoY Change 1086.21%
Acquisitions
YoY Change
Other Investing Activities -$48.78M
YoY Change
Cash From Investing Activities -$48.80M -$30.71K -$2.589K
YoY Change 1086.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.64M $70.67M $1.763M
YoY Change 3908.1% -91.5%
NET CHANGE
Cash From Operating Activities -4.390M -$3.673M -$5.185M
Cash From Investing Activities -48.80M -$30.71K -$2.589K
Cash From Financing Activities 10.64M $70.67M $1.763M
Net Change In Cash -42.55M $66.96M -$3.425M
YoY Change 1734.05% -2055.38% -120.9%
FREE CASH FLOW
Cash From Operating Activities -$4.390M -$3.673M -$5.185M
Capital Expenditures -$20.00K $30.71K $2.589K
Free Cash Flow -$4.370M -$3.704M -$5.188M
YoY Change 88.36% -28.6% 18.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29000000 USD
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29000000 USD
CY2015Q1 us-gaap Goodwill
Goodwill
12737350 USD
CY2014Q4 us-gaap Goodwill
Goodwill
12737350 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96054082 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29091113 USD
CY2015Q1 us-gaap Other Assets Current
OtherAssetsCurrent
283836 USD
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
125284 USD
CY2015Q1 us-gaap Assets Current
AssetsCurrent
96337918 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
29216397 USD
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
173248 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
156441 USD
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2128383 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1054021 USD
CY2015Q1 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
11600000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
11600000 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-142657025 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-135512072 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
124619032 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
58571172 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
138347415 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
71225193 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
509363 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
23540 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
10350 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
29000000 USD
CY2014Q3 asmb Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill
12737350 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
42297209 USD
CY2014Q3 asmb Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accrued Expenses
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses
874113 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
11600000 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
12474113 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
29823096 USD
CY2014Q3 asmb Noncash Or Part Noncash Acquisition Fair Value Of Vested Options And Restricted Stock
NoncashOrPartNoncashAcquisitionFairValueOfVestedOptionsAndRestrictedStock
758948 USD
CY2014Q3 asmb Noncash Or Part Noncash Acquisition Share Exchange Business Combination
NoncashOrPartNoncashAcquisitionShareExchangeBusinessCombination
29064148 USD
CY2014Q3 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
4008848 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
621651 shares
CY2015Q1 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
29823096 USD
CY2015Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
12737350 USD
CY2015Q1 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
0 USD
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16250814 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10672059 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16250814 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10672059 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3237851 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
12500 shares
CY2015Q1 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
266666 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2960485 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1381696 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.26
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.42
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.2
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.19
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.21
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5187924 USD
CY2015Q1 asmb Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodTotalIntrinsicValue
0 USD
CY2015Q1 asmb Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodTotalIntrinsicValue
0 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
20886161 USD
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
9717342 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
9.42
CY2015Q1 asmb Future Stock Based Compensation Expense Remainder Of Fiscal Year
FutureStockBasedCompensationExpenseRemainderOfFiscalYear
3033545 USD
CY2015Q1 asmb Future Stock Based Compensation Expense Year Two
FutureStockBasedCompensationExpenseYearTwo
1262438 USD
CY2015Q1 asmb Future Stock Based Compensation Expense Year Three
FutureStockBasedCompensationExpenseYearThree
44645 USD
CY2015Q1 asmb Future Stock Based Compensation Expense Total
FutureStockBasedCompensationExpenseTotal
4340628 USD
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y3M18D
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2973690 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3834434 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1136461 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3368784 USD
CY2014Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4110151 USD
CY2015Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7203218 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4110151 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7203218 USD
CY2014Q1 us-gaap Interest Income Other
InterestIncomeOther
40234 USD
CY2015Q1 us-gaap Interest Income Other
InterestIncomeOther
58265 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
40234 USD
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
58265 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-4069917 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-7144953 USD
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.92
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.64
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4418940 shares
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11176580 shares
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
254717 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2585780 USD
CY2014Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
195522 USD
CY2015Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
158552 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5185061 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3673353 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2589 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30711 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2589 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30711 USD
CY2014Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
1763104 USD
CY2015Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
70499993 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1763104 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
70667033 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3424546 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
66962969 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27061268 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23636722 USD
CY2014Q1 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
440 USD
CY2015Q1 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
CY2015Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2585780 USD
CY2015Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>Use of Estimates</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period.&#160;&#160;Actual results could differ from those estimates.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Significant estimates inherent in the preparation of the accompanying financial statements include recoverability and useful lives of long-lived assets, the valuation allowance related to the Company&#8217;s deferred tax assets and the fair value of stock options and warrants granted to employees, consultants, directors, investors, licensors, placement agents and underwriters.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Certain of the Company&#8217;s estimates, including the carrying amount of the intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company&#8217;s estimates and could cause actual results to differ from those estimates and assumptions.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q3 us-gaap Security Deposit
SecurityDeposit
16606 USD
CY2015Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
1250843 USD
CY2014Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
907601 USD
CY2015Q1 us-gaap Security Deposit
SecurityDeposit
98899 USD
CY2014Q4 us-gaap Security Deposit
SecurityDeposit
115005 USD
CY2015Q1 asmb Stock Issued During Period Value Common Stock Issued
StockIssuedDuringPeriodValueCommonStockIssued
70499993 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1179419 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
283242 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3814 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
731120 USD
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
877540 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
146420 USD
CY2015Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
36145 USD
CY2015Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
8400 USD
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
762834 shares
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3231246 shares
CY2014Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
0 USD
CY2014Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-4495684 USD
CY2014Q1 asmb Business Acquisition Pro Forma Earnings Per Share Basic And Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted
-0.54
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17177106 shares
CY2015Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
60000 USD
CY2015Q1 dei Document Type
DocumentType
10-Q
CY2015Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q1 dei Entity Registrant Name
EntityRegistrantName
ASSEMBLY BIOSCIENCES, INC.
CY2015Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001426800
CY2015Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q1 dei Trading Symbol
TradingSymbol
ASMB
CY2015Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
167040 USD
CY2014Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 USD
CY2015Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-16106 USD
CY2014Q1 asmb Accrued Offering Cost Related To Issuance Of Common Stock
AccruedOfferingCostRelatedToIssuanceOfCommonStock
0 USD
CY2015Q1 asmb Accrued Offering Cost Related To Issuance Of Common Stock
AccruedOfferingCostRelatedToIssuanceOfCommonStock
167040 USD
CY2014Q1 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
CY2015Q1 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
60000 USD
CY2015Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
237393 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
206682 USD
CY2015Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
64145 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
50241 USD
CY2015Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
253156 USD
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
0 USD
CY2015Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
491170 USD
CY2014Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
0 USD
CY2015Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
19000 USD
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
19860 USD
CY2015Q1 asmb Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
15000 USD
CY2014Q4 asmb Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
27346 USD
CY2015Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
99214 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
99214 USD
CY2014Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1959000 shares
CY2014Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
8.04
CY2014Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14963000 USD
CY2015Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
23200 shares
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.20
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
140128 USD
CY2015Q1 asmb Business Acquisition Intangible Expected Tax Deductible Amount
BusinessAcquisitionIntangibleExpectedTaxDeductibleAmount
0 USD

Files In Submission

Name View Source Status
0001144204-15-028776-index-headers.html Edgar Link pending
0001144204-15-028776-index.html Edgar Link pending
0001144204-15-028776.txt Edgar Link pending
0001144204-15-028776-xbrl.zip Edgar Link pending
asmb-20150331.xml Edgar Link completed
asmb-20150331.xsd Edgar Link pending
asmb-20150331_cal.xml Edgar Link unprocessable
asmb-20150331_def.xml Edgar Link unprocessable
asmb-20150331_lab.xml Edgar Link unprocessable
asmb-20150331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v409214_10q.htm Edgar Link pending
v409214_ex31-1.htm Edgar Link pending
v409214_ex31-2.htm Edgar Link pending
v409214_ex32-1.htm Edgar Link pending
v409214_ex32-2.htm Edgar Link pending